Searching for guideline‑recommended
genomic information?


Searching for guideline‑recommended
genomic information?

Get results faster.

Guide treatment decisions
in 7 days with Liquid Biopsy.

Comprehensive genomic profiling from
a blood sample. Fast.

Easy to interpret report informs first-line decisions and beyond

Blood Sample

2x 10 ml tubes of blood

7 days

Comprehensive genomic
profiling results in
only 7 days

Take action

Clinically relevant alterations
in 70+ cancer related genes.

For patients with advanced solid tumour cancers

  • Before 1st Line Treatment

    Get ahead of the challenges of tissue testing in advanced NSCLC by utilizing Guardant360® to guide 1st line treatment decisions

  • At Progression

    Get genomic information on over 70+ genes, including MSI across multiple solid tumors to help find cancer therapies and clinical trials


Prospective study of 323 NSCLC patients found Guardant360® improved alteration detection1

were unable to get complete genomic results from tissue biopsy

had targetable alterations detected by Guardant360® and tissue testing (n=82) versus tissue testing alone (n=47)

treated based on Guardant360® had a response or stable disease


Subscribe to our Newsletter

to stay up to date with information
on Liquid Biopsy and Guardant Health services

Consistently High Concordance with Tissue

for targetable alterations before 1st NSCLC therapy1

Consistently High Concordance with Tissue

  • Best-in-class detection

  • Extensively peer reviewed and published

  • Published analytical and clinical validation (refs)

  • Over 150 peer reviewed publications, more than 50 of which include associated clinical outcomes

Tissue has limitations beyond your control

  • Treatment delays
  • Patient burden
  • Finite resource
  • Practice/staff burden

Relying solely on tissue leads to undergenotyping

~ 1 in 2 NSCLC patients are unable to get guideline-recommended genes for NSCLC2-6


Everything you need
to get started


  • On-call support for healthcare professionals and patients
  • Easy access to reports via online portal, or app

    This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.